FATE Competitors & Alternatives
Compare Fate Therapeutics Inc with similar stocks in the same industry
Biotechnology
FATE
Main Stock$2.92
Tradestie Score
60
Market Cap
$144.16M
Revenue Growth
-0.2%
Analyst Upside
+85.3%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$2.03
|
$350.98M | - | 57 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.16
|
$341.56M | - | 59 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.46
|
$332.96M | - | 55 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.58
|
$328.62M | - | 58 | Compare |
|
EDIT
Editas Medicine, Inc. Common Stock
|
$3.65
|
$319.22M | - | 55 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$15.10
|
$308.74M | - | 60 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.83
|
$304.12M | - | 59 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.51
|
$297.23M | - | 58 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$37.93
|
$293.03M | - | 64 | Compare |
|
OMER
Omeros Corporation
|
$9.28
|
$281.75M | 8.3 | 51 | Compare |
More FATE Analysis
Data updated: Jul 05, 2026 | Industry: Biotechnology (SIC 2836)
234 stocks in this industry